News

PathPresenter Partners with Leading Global Cancer Center to Integrate AI Module for Oncology Research

PathPresenter, an AVANT BIO portfolio company, has partnered with Memorial Sloan Kettering Cancer Center (MSK) to integrate an AI-powered module into its platform, advancing oncology research and diagnostics. This collaboration leverages AI-driven pathology analysis to accelerate cancer research, enhance diagnostic precision, and improve patient outcomes by providing pathologists and clinicians with more efficient insights.

Press Release